Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability

Echocardiography

Volumn 22, Issue 2, 2005, Pages 165-177

  Ghesani, Munir ^a,b   DePuey, E Gordon ^a   Rozanski, Alan ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

F 18 FDG; Myocardial viability; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ARTICLE; COLLIMATOR; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HALF LIFE TIME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INSULIN BLOOD LEVEL; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

ECHOCARDIOGRAPHY, STRESS; FLUORODEOXYGLUCOSE F18; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TECHNETIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 13444253901     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2005.04032.x     Document Type: Article

References (81)

1. Bonow RO, Dilsizian V: Thallium-201 for assessing myocardial viability. Semin Nucl Med 1991;21:230.
2. Rahimtoola SH: The hibernating myocardium. Am Heart J 1989;117:211.
3. Bax J, Wahba FF, Van der Wall EE: Myocardial viability/hibernation. In Iskandrian AE, Verani MS (eds): Nuclear Cardiac Imaging. New York, Oxford University Press, 2003.
4. Bolukoglu H, Liedtke JA, Nellis SH, et al: An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol 1992;263: H20.
5. Vanoverschelde JLJ, Wijns W, Depre C, et al: Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513.
6. Dilsizian V, Bonow RO: Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1.
7. Kim RJ, Wu E, Rafael A, et al: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1458.
8. Gerber BL, Garot J, Bluemke DA, et al: Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089.
9. Ramani K, Judd RM, Holly TA, et al: Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998;98:2687-2694.
10. Bisi G, Sciagra R, Santoro GM, et al: Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282.
11. Leoncini M, Marcucci G, Sciagra R, et al: Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: Comparison with two-dimensional echocardiography. J Nucl Cardiol 2000;7:426.
12. Sciagra R, Pellegri M, Pupi A, et al: Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739.
13. DiCarli M, Davidson M, Little R, et al: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527.
14. Dilsizian V, Arrighi JA, Diodati JG, et al: Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation 1994;89:578.
15. Maki M, Luotolahti M, Nuutila P, et al: Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658-1666.
16. Sun D, Nguyen N, DeGrado T, et al: Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 1994;89:793-798.
17. Hutchins G, Schwaiger M, Rosenspire K, et al: Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-1042.
18. Tillisch J, Brunken R, Marshall R, et al: Reversibility of cardiac wall motion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884-888.
19. Tamaki N, Yonekura Y, Yamashita K, et al: Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
20. Eitzman D, Al-Aouar Z, Kanter HL, et al: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-565.
21. Lee KS, Marwick TH, Cook SA, et al: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-2694.
22. Tamaki N, Kawamoto M, Takahashi N, et al: Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction. Comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621-1627.
23. Di Carli M, Asgarzadie F, Schelbert HR, et al: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-3444.
24. Verani MS, Taillefer R, Iskandrian AE, et al: 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicente IPPA Viability Trial Investigators. 1231-iodophenyl pentadecanoic acid. J Nucl Med 2001;41:1299.
25. Chaudhry FA, Tauke JT, Alessandrini RS, et al: Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999;34:730.
26. Goldstein RA, Mullani NA, Wong WH, et al: Positron imaging of myocardial infarction with Rubidium-82. J Nucl Med 1986;27:1824-1829.
27. Goldstein RA: Rubidium-82 kinetics after coronary occlusion: Temporal relation of net myocardial accumulation and viability in open-chested dogs. J Nucl Med 1986;27:1456-1461.
28. Masazumi A, Links J, Takatsu H, et al: Regional Rb-82 washout assessed by PET reflects the severity and time course of myocardial ischemia-reperfusion injury. J Am Coll Cardiol 1993;21:460A.
29. De Silva R, Yamamoto Y, Rhodes CG, et al: Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-1742.
30. Yamamoto Y, De Silva R, Rhodes C, et al: A new Strategy for the assessment of viable myocardium and regional myocardial blood flow using O-15 water and dynamic positron emission tomography. Circulation 1992;86:167-178.
31. Choi Y, Huang SC, Hawkins RA, et al: A simplified method for quantification of myocardial blood-flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med 1993;34(3):488-497.
32. Hutchins GD, Schwaiger M, Rosenspire KC, et al: Noninvasive quantification of regional blood-flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15(5):1032-1042.
33. Bax JJ, Veening MA, Visser FC, et al: Optimal metabolic conditions during fluorine-18 fluorodeoxyglocuse imaging; a comparative study using different protocols. Eur J Nucl Med 1997;24(1):35-41.
34. Gambhir SS, Schwaiger M, Huang SC, et al: Simple noninvasive quantification method for measuring myocardial glucose-utilization in humans employing positron emission tomography and F-18 deoxyglucose. J Nucl Med 1989;30(3):359-366.
35. Martin WH, Jones RC, Delbeke D, et al: A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography. Eur J Nucl Med 1997;24(10):1291-1297.
36. Knuuti MJ, Nuutila P, Ruotsalainen U, et al: Euglycemic hyperinsulinemic clamp and oral glucose-load in stimulating myocardial glucose-utilization during positron emission tomography. J Nucl Med 1992;33(7):1255-1262.
37. Vitale GD, deKemp RA, Ruddy TD, et al: Myocardial glucose utilization and optimization of F-18-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 2001;42(12):1730-1736.
38. Hicks R, Von Dohl J, Lee K, et al: Insulin-glucose clamp for standardization of metabolic conditions during F-18 fluoro-deoxyglucose PET imaging. J Am Coll Cardiol 1991;17:381A.
39. Ohtake T, Yokoyama I, Watanabe, et al: Myocardial glucose-metabolism in noninsulin-dependent diabetes-mellitus patients evaluated by Fdg-pet. J Nucl Med 1995;36(3):456-463.
40. Schöder H, Campisi R, Ohtake T, et al: Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 1999;33:1328-1337.
41. Lucignani G, Paolini G, Landoni C, et al: Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-881.
42. Schwaiger M., ed. Cardiac Positron Emission Tomography. Boston, Kluwer Academic Publishers, 1996, p. 366.
43. Choi Y, Brunken RC, Hawkins RA, et al: Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20:308-318.
44. Gropler RJ, Siegel BA, Lee KJ, et al: Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans (see comments). J Nucl Med 1990;31:1749-1756.
45. Czernin J, Porenta G, Brunken R, et al: Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 1993;88:884-895.
46. Maes A, Moretalmans L, Nuyts J, et al: Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction. Eur Heart J 1997;18:954-962.
47. Bergmann SR, Herrero P, Markham J, et al: Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989;14:639-652.
48. Aruajo L, Lammertsma A, Rhodes C, et al: Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15 labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-885.
49. Gould K: PET perfusion imaging and nuclear cardiology. J Nucl Med 1991;32:579-606.
50. Gropler RJ, Siegel BA, Sampathkumaran K, et al: Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992;19:989-997.
51. Gropler RJ, Geltman EM, Sampathkumaran K, et al: Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992;20:569-577.
52. Gropler RJ, Geltman EM, Sampathkumaran K, et al: Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-1597.
53. Vanoverschelde J-LJ, Melin J, Bol A, et al: Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Circulation 1992;85:9-21.
54. DePuey EG, Nichols K, Salensky H, et al: Gated Tc-99m sestamibi correlates of myocardial viability assessed with rest/delayed Tl-201 SPECT. J Nucl Med 1995;36:56P.
55. DiCarli MF, Asgarzadie F, Schelbert HR, et al: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436.
56. Bax JJ, Poldermans D, Elhendy A, et al: Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26: 142.
57. Marin-Neto JA, Dilsizian V, Arrighi JA, et al: Thallium Scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. Am J Cardiol 1998;82(9):1001-1007.
58. Brunken RC, Mody FV, Hawkins RA, et al: Positron emission tomography detects metabolic activity in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects. Circulation 1992;86:1357-1369.
59. Bonow RO, Dilsizian V, Cuocolo A, et al: Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
60. Akinboboye OO, Idris O, Cannon PJ, et al: Usefulness of positron emission tomography in defining myocardial viability in patients referred for cardiac transplantation. Am J Cardiol 1999;83:1271-1274.
61. Dreyfus GD, Duboc D, Blasco A, et al: Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402-1408.
62. Shirani J, Chandra M, Sonnenblick E: Morphological and echocardiographic features of viable and nonviable myocardium. In Dilsizian V (ed): Myocardial Viability: A Clinical and Scientific Treatise. Armonk, N.Y., Futura Publishing Co, Inc, 2000, pp. 214-215.
63. Pierard LA, Landsheere CMD, Berthe C, et al: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
64. Bax JJ, Wijns W, Cornel JH, et al: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460.
65. Klein C, Nekolla SG, Bengel FM, et al: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: Comparison with positron emission tomography. Circulation 2002;105(2):162-167.
66. Baer FM, Voth E, Schneider CA, et al: Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91(4):1006-1015.
67. Kuhl H, Beek AM, van der Weerdt AP, et al: Myocardial viability in chronic ischemic heart disease. Comparison of contrast-enhanced magnetic resonance imaging with F-18 Fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-1348.
68. Vom Dahl J, Eitzman D, Al-Aouar A, et al: Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-2366.
69. Di Carli MF, Davidson M, Little R, et al: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-533.
70. Haas F, Haehnel CJ, Picker W, et al: Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-1700.
71. Landoni C, Lucignani G, Paolini G, et al: Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability. J Cardiovasc Surg 1999;40:363-372.
72. Schelbert H: F-18-deoxyglucose and the assessment of myocardial viability. Semin Nucl Med 2002;32(1): 60-69.
73. Di Carli MF, Maddahi J, Rokhsar S, et al: Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997-1004.
74. Tamaki N, Ohtani H, Yonekura Y, et al: Significance of fill-in after thallium-201 reinjection following delayed imaging: Comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-1623.
75. Marwick T, MacIntyre W, Lafont A, et al: Metabolic responses of hibernating and infracted myocardium to revascularization: A follow-up study of regional perfusion, function, and metabolism. Circulation 1992;85:1347-1353.
76. Carrel T, Jenni R, Haubold-Reuter S, et al: Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothoracic Surg 1992;6:479-184.
77. Knuuti MJ, Saraste M, Nuutila P, et al: Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994;127:785-796.
78. Tamaki N, Kawamoto M, Tadamura E, et al: Prediction of reversible ischemia after revascularization: Perfusion and metabolic studies using positron emission tomography. Circulation 1995;91:1697-1705.
79. Maes A, Flameng W, Nuyts J, et al: Histological alterations in chronically hypoperfused myocardium. Circulation 1994;90:735-745.
80. Gerber BL, Vanoverschelde JL, Bol A, et al: Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-659.
81. Schoder H, Schelbert H: Positron emission tomography for the assessment of myocardial viability: Noninvasive approach to cardiac pathophysiology. In Dilsizian V (ed): Myocardial Viability: A Clinical and Scientific Treatise.. Armonk, N.Y., Futura Publishing Co, Inc, 2000;391-173.